MiRNA Dysregulation in Childhood Hematological Cancer
AbstractFor decades, cancer biology focused largely on the protein-encoding genes that have clear roles in tumor development or progression: cell-cycle control, apoptotic evasion, genome instability, drug resistance, or signaling pathways that stimulate growth, angiogenesis, or metastasis. MicroRNAs (miRNAs), however, represent one of the more abundant classes of cell modulators in multicellular organisms and largely contribute to regulating gene expression. Many of the ~2500 miRNAs discovered to date in humans regulate vital biological processes, and their aberrant expression results in pathological and malignant outcomes. In this review, we highlight what has been learned about the roles of miRNAs in some of the most common human pediatric leukemias and lymphomas, along with their value as diagnostic/prognostic factors. View Full-Text
- Supplementary File 1:
ZIP-Document (ZIP, 35 KB)
Share & Cite This Article
Carvalho de Oliveira, J.; Molinari Roberto, G.; Baroni, M.; Bezerra Salomão, K.; Alejandra Pezuk, J.; Sol Brassesco, M. MiRNA Dysregulation in Childhood Hematological Cancer. Int. J. Mol. Sci. 2018, 19, 2688.
Carvalho de Oliveira J, Molinari Roberto G, Baroni M, Bezerra Salomão K, Alejandra Pezuk J, Sol Brassesco M. MiRNA Dysregulation in Childhood Hematological Cancer. International Journal of Molecular Sciences. 2018; 19(9):2688.Chicago/Turabian Style
Carvalho de Oliveira, Jaqueline; Molinari Roberto, Gabriela; Baroni, Mirella; Bezerra Salomão, Karina; Alejandra Pezuk, Julia; Sol Brassesco, María. 2018. "MiRNA Dysregulation in Childhood Hematological Cancer." Int. J. Mol. Sci. 19, no. 9: 2688.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.